CT-FFR in Chronic Coronary Syndrome: A multicenter look at risk and outcomes
Official title: Assessment of Coronary Computed Tomography-Derived Fractional Flow Reserve in Patients With Chronic Coronary Syndrome: A Prospective Multicenter Cohort Study
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07659119 · Data updated 2026-11-12
This study tests whether CT-derived fractional flow reserve (CT-FFR) from prior CT scans can help predict 1-year major adverse cardiovascular events in adults with chronic coronary syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | September 23, 2024 |
| Main results expected | May 31, 2030 |
| Study ends | May 31, 2034 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT07659119 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with chronic coronary syndrome who had a CCTA and valid CT-FFR results and consent to participate.
✕Probably not a fit
Patients without abnormal CT-FFR results or those not at risk for near-term events may see limited direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter, observational study conducted in China to see if abnormal CT-FFR results from CCTA scans are linked to higher risk of major adverse clinical events over 1 year in patients with chronic coronary syndrome. Researchers will analyze real-world data from patients who have already undergone CCTA and CT-FFR testing, focusing on functional significance beyond anatomy. The study does not assign treatments but aims to clarify how CT-FFR findings could influence risk stratification and management decisions. Enrollment includes adults with CCS who had valid CT-FFR results, excluding those with ACS or poor image quality, and who consent to follow-up. Outcomes will help determine the prognostic value of CT-FFR in routine clinical practice.
Why it matters
Potential benefit: If CT-FFR proves prognostic, clinicians may use it to better tailor treatment plans and follow-up strategies for CCS patients.
How similar studies have gone: Previous work suggests functional testing like CT-FFR can aid risk stratification, but prospective multicenter data in CCS remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Clinical diagnosis of chronic coronary syndrome (CCS). * Completed coronary computed tomography angiography (CCTA) examination and successfully obtained CT-derived fractional flow reserve (CT-FFR) results. * The subject or their legal representative voluntarily participates in this study and has signed the written informed consent form. Exclusion Criteria: * Acute coronary syndrome (ACS), including ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or acute episodes of unstable angina. * Unable to obtain valid CT-FFR results, or the image quality is insufficient to support analysis. * Pregnant patients or those who intend to become pregnant during the study period. * Non-cardiac comorbidities indicating a life expectancy of less than one year. * Failure to sign the informed consent form. * Inability to complete the follow-up or explicit refusal to participate in the follow-up. * Patients with cognitive impairment or psychiatric disorders confirmed by clinical diagnosis or investigator assessment. * Patients who are illiterate or semi-literate, or who, due to any visual impairment or reading/writing disability, are unable to independently read the subject information sheet without assistance and are unable to personally provide written informed consent. * Any other conditions deemed unsuitable for participation in this study by the investigators
Where it's running
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Jun Jiang, MD — Second Affiliated Hospital, Zhejiang University, School of Medicine
- Study coordinator: Jun Jiang, MD
- Email: jiang-jun@zju.edu.cn
- Phone: +(86) 13588706891
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.